The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours | Zendy

Grażyna Łapińska | Zendy; Małgorzata Anita Bryszewska | Zendy; Agnieszka Fijołek-Warszewska | Zendy; Izabella Kozłowicz-Gudzińska | Zendy; Paweł Ochman | Zendy; Agata Sackiewicz-Słaby | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours

Author(s) -

Grażyna Łapińska,

Małgorzata Anita Bryszewska,

Agnieszka Fijołek-Warszewska,

Izabella Kozłowicz-Gudzińska,

Paweł Ochman,

Agata Sackiewicz-Słaby

Publication year - 2011

Publication title -

nuclear medicine review

Language(s) - English

Resource type - Journals

eISSN - 1644-4345

pISSN - 1506-9680

DOI - 10.5603/nmr.2011.0004

Subject(s) - somatostatin receptor , medicine , medullary thyroid cancer , neuroendocrine tumors , positron emission tomography , pet ct , radiology , radionuclide therapy , primary tumor , nuclear medicine , thyroid carcinoma , cancer , somatostatin , thyroid , pathology , metastasis

Positron emission tomography (PET) combined with computer tomography (CT) using (68)Ga-DOTATATE is a promising method for the evaluation of patients with recognised or suspected neuroendocrine tumours (NET). The aim of this study was to assess the diagnostic value of (68)Ga-DOTATATE PET/CT in the visualisation of the expression of somatostatin receptors (SSTR) and identification of new lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research